Medical Oddities: Prayer for Pain? - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Medical Oddities: Prayer for Pain?

This week’s research collection showed that biology, behavior, and environment often intersect in unexpected ways.

  • By

  • Teraya Smith

  • June 3, 2026

  • 6 min

Share

Clinical Scorecard: Prayer for Pain?

At a Glance

CategoryDetail
Condition
Key MechanismsIn-person Christian proximal intercessory prayer vs. relaxing music (source needed)
Target Population
Care Setting

Key Highlights

  • 162 participants with pain reported 1- to 2-point greater reductions in pain after prayer intervention (source needed).
  • 111 participants with anxiety showed improvements on GAD-7 assessments through 6 weeks (source needed).
  • Study population was predominantly Black (83%), female (78%), and low-income (source needed).
  • No adverse events reported; 97% of participants were neutral or agreed to future prayer opportunities (source needed).

Guideline-Based Recommendations

Diagnosis

    Management

    • Consider offering prayer as a complementary intervention for pain and anxiety (source needed).

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Prayer may provide a unique intervention (source needed).

        Clinical Best Practices

          Related Resources & Content

          Original Source(s)

          Medical Oddities: Prayer for Pain?

          • by Teraya Smith

          • June 3, 2026

          Related Content

          Paragraph recall may flag cognitive impairment

          Linguistic patterns captured information beyond traditional memory scoring and were associated with cognitive performance over 7 years.

          Misleading AI summaries may alter recall

          Participants exposed to inaccurate postevent summaries were less likely to correctly remember key details from videos they had previously watched.

          FDA approves pritelivir for refractory HSV lesions

          In a phase 3 trial, complete lesion healing occurred in 63% of patients receiving pritelivir vs. 34% receiving comparator treatments.